These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20597165)

  • 1. HIV vaccine acceptability: a systematic review and meta-analysis.
    Newman PA; Logie C
    AIDS; 2010 Jul; 24(11):1749-56. PubMed ID: 20597165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV vaccine acceptability among men: a systematic review and meta-analysis.
    Newman PA; Logie CH; Doukas N; Asakura K
    Sex Transm Infect; 2013 Nov; 89(7):568-74. PubMed ID: 23828943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand.
    Newman PA; Roungprakhon S; Tepjan S; Yim S
    Vaccine; 2010 Jan; 28(4):958-64. PubMed ID: 19925897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics.
    Newman PA; Duan N; Lee SJ; Rudy ET; Seiden DS; Kakinami L; Cunningham WE
    Vaccine; 2006 Mar; 24(12):2094-101. PubMed ID: 16332402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Sisters, Mothers, Daughters and Aunties": HIV vaccine acceptability among African, Caribbean and other Black women in Toronto.
    Weaver J; Newman PA; Williams CC; Massaquoi N; Brown M
    Can J Public Health; 2013 Aug; 104(5):e413-7. PubMed ID: 24183184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach.
    Lee SJ; Brooks RA; Newman PA; Seiden D; Sangthong R; Duan N
    AIDS Care; 2008 Nov; 20(10):1161-8. PubMed ID: 18608068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine acceptability among high-risk drug users in Appalachia: a cross-sectional study.
    Young AM; DiClemente RJ; Halgin DS; Sterk CE; Havens JR
    BMC Public Health; 2014 May; 14():537. PubMed ID: 24885970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine characteristics and acceptability of HIV immunization among adolescents.
    Zimet GD; Blythe MJ; Fortenberry JD
    Int J STD AIDS; 2000 Mar; 11(3):143-9. PubMed ID: 10726935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.
    Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S
    BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an HIV vaccine attitudes scale to predict HIV vaccine acceptability among vulnerable populations: L.A. VOICES.
    Lee SJ; Newman PA; Duan N; Cunningham WE
    Vaccine; 2014 Sep; 32(39):5013-8. PubMed ID: 25045817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' high acceptability of a future therapeutic HIV vaccine in France: a French paradox?
    Dimi S; Zucman D; Chassany O; Lalanne C; Prazuck T; Mortier E; Majerholc C; Aubin-Auger I; Verger P; Duracinsky M
    BMC Infect Dis; 2019 May; 19(1):401. PubMed ID: 31072394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceptability of vaccination against HIV: A mapping of Togolese people's positions.
    Kpanake L; Gbandey S; Sorum PC; Mullet E
    J Health Psychol; 2018 May; 23(6):800-806. PubMed ID: 27611628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acceptability of HIV immunization: examining vaccine characteristics as determining factors.
    Liau A; Zimet GD
    AIDS Care; 2001 Oct; 13(5):643-50. PubMed ID: 11571011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of conjoint analysis to assess HIV vaccine acceptability: feasibility of an innovation in the assessment of consumer health-care preferences.
    Lee SJ; Newman PA; Comulada WS; Cunningham WE; Duan N
    Int J STD AIDS; 2012 Apr; 23(4):235-41. PubMed ID: 22581945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake.
    Rudy ET; Newman PA; Duan N; Kelly EM; Roberts KJ; Seiden DS
    AIDS Educ Prev; 2005 Jun; 17(3):253-67. PubMed ID: 16006211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health beliefs and intention to get immunized for HIV.
    Zimet GD; Liau A; Fortenberry VD
    J Adolesc Health; 1997 May; 20(5):354-9. PubMed ID: 9168382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000.
    AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive HIV vaccine acceptability and behavioral risk compensation among a random sample of high-risk adults in Los Angeles (LA VOICES).
    Newman PA; Lee SJ; Duan N; Rudy E; Nakazono TK; Boscardin J; Kakinami L; Shoptaw S; Diamant A; Cunningham WE
    Health Serv Res; 2009 Dec; 44(6):2167-79. PubMed ID: 19780857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What can HIV vaccine trials teach us about future HIV vaccine dissemination?
    Newman PA; Duan N; Kakinami L; Roberts K
    Vaccine; 2008 May; 26(20):2528-36. PubMed ID: 18420313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.